Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103408573B reveals novel NHC-catalyzed boration. Achieve cost reduction in API intermediate manufacturing with high-purity boronic acid derivatives.
Novel process for 1H-imidazo[4,5-c]quinoline-4-amine via cyano intermediates. High purity, scalable route for API manufacturing avoiding harsh conditions.
Novel palladium-copper catalytic method for phenanthrene intermediates ensures high purity and scalable production for global pharmaceutical supply chains efficiently.
Patent CN106928191B reveals improved Lansoprazole production with higher purity and yield. This process offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel low-temperature halogenated solvent process for high-purity imidazole ester. Reduces cost and eliminates chromatography for reliable pharmaceutical intermediate supply.
Patent CN102964418B details a high-yield synthesis for desogestrel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN105906680A reveals high-yield desogestrel route exceeding 90% total yield. This technology reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Advanced triazole synthesis patent offers streamlined production for pharmaceutical intermediates ensuring supply chain stability and cost efficiency.
Novel patent CN104945265B offers high-yield 2-aminoindene synthesis. Reduces costs and improves supply chain reliability for global pharma manufacturers.
Patent CN104230853A details a robust synthesis route for pharmaceutical intermediates. This method offers significant supply chain reliability and cost optimization advantages.
Patent CN103880883A details a novel P2O5-mediated route for Tenofovir Dipivoxil, reducing impurities and enhancing supply chain reliability for API manufacturers.
Patent CN116574707B reveals high-activity LeuDH mutant for L-tert-leucine. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN112694487B details a novel silanization route for Cefprozil, ensuring European Pharmacopoeia compliance and superior impurity control for global supply chains.
Novel synthetic route for Benzochromene derivatives offers cost reduction and scalable production for pharmaceutical intermediates supply chain reliability.
Novel patent CN110128347A enables high-purity indazole intermediate production with scalable carbonylation technology for reliable pharmaceutical supply chains.
Patent CN1526711A details a scalable Reformatsky process for Gemcitabine intermediates, offering high stereoselectivity and cost reduction in pharmaceutical manufacturing.
Patent CN104672189A details Ru-catalyzed asymmetric hydrogen transfer for high-purity chiral alcohols. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116730905B reveals Pd-catalyzed carbonylation for spiroindoline. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediate manufacturing.
Patent CN113968815B reveals a novel apalutamide intermediate synthesis route offering high purity and cost reduction for pharmaceutical manufacturing supply chains.
Novel two-step synthesis for Vonoprazan fumarate intermediate offers high purity and cost efficiency. Reliable supply chain solution for pharmaceutical intermediates manufacturing globally.